Pipeline Information

Boehringer Ingelheim is taking on cancer through a dedicated commitment to delivering cancer cell-directed therapies, innovative immuno-oncology strategies and smart combination approaches, which can transform the lives of patients.

Oncology Pipeline

Our clinical development pipeline overview

Our clinical development pipeline includes cancer cell-directed compounds, immuno-oncology compounds and compounds targeting both cancer cells and immune cells.

Download

Oncology pipeline website

Boehringer Ingelheim is pursuing leading science to deliver novel cancer cell-directed therapies, innovative immuno-oncology strategies, and smart combination approaches that can transform the lives of patients.

Visit website

Our Oncology Pipeline overview

Gain an overview of our oncology pipeline, which includes cancer cell-directed compounds, immuno-oncology compounds and compounds targeting both cancer cells and immune cells.

Download

Find out more about the Oncology Pipeline at Boehringer Ingelheim